21-09-2026 18:12 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Deliverable Volume
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 409.45
NSE Code MANKIND
Dividend Yield % 0.04
Market Cap 1003637.61
P/E 46.03
EPS 52.79
Face Value 1  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
18-Sep-2026 80938 77144 95.31
17-Sep-2026 5368 3435 63.99
16-Sep-2026 40362 32963 81.67
15-Sep-2026 9458 5651 59.75
11-Sep-2026 15026 6786 45.16
10-Sep-2026 7011 4047 57.72
09-Sep-2026 3990 2358 59.10
08-Sep-2026 6018 3582 59.52
07-Sep-2026 4904 2407 49.08
04-Sep-2026 5784 2864 49.52
03-Sep-2026 3738 1940 51.90
02-Sep-2026 14327 7818 54.57
01-Sep-2026 6115 3912 63.97
Page 1 of 1
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.